USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/30372
Title: Combination of anti-VEGF injections and microsecond pulse cyclophotocoagulation in the management of neovascular glaucoma
Authors: Pălărie, Natalia
Palii, Natalia
Issue Date: 2024
Publisher: CEP Medicina
Citation: PĂLĂRIE, Natalia; PALII, Natalia. Combination of anti-VEGF injections and microsecond pulse cyclophotocoagulation in the management of neovascular glaucoma. In: The 19th SEEOS Congress: abstract book, Oct. 18-19th, 2024 / org. commit.: Eugeniu Bendelic [et al.]. Chişinău: CEP Medicina, 2024, p.41. ISBN 978-9975-82-393-7.
Abstract: Purpose: Neovascular glaucoma (NVG) is a particularly challenging and prognostically poor form of glaucoma. This research evaluated the effectiveness of a dual treatment approach combining intraocular VEGF inhibitor injection and microsecond pulse cyclophotocoagulation (µCPC) for managing secondary neovascular glaucoma. Methods: The study included 58 patients (67 eyes) suffering from secondary neovascular glaucoma due to diabetes or thrombosis of the central retinal vein or its branches. The best corrected visual acuity (BCVA) ranged from hand motion to 0.4, with an average initial intraocular pressure (IOP) of 42 ± 12 mm Hg. Treatment consisted of an intraocular injection of Bevacizumab, a VEGF inhibitor, followed within 5-7 days by 810 nm infrared diode laser application in microsecond pulse mode at 2000 mW for a total duration of 220-240 seconds (145 – 160 J) and a duty cycle of 33.3%. Treatment success was determined by a decrease in anti-glaucoma drop (AGD) usage and maintaining an IOP between 11-21 mm Hg at the final followup. Follow-up assessments occurred at baseline, 1 week, and 1, 3, and 6 months post-treatment. Results: On average, 1.3 treatments were administered per eye, with 20 eyes (30%) needing additional treatment with continuous-wave CPC within the first month. The mean IOP dropped to 28.5 ± 5.0 mm Hg after 1 week, 23.0 ± 5.3 mm Hg after 1 month, 19.5 ± 3.2 mm Hg after 3 months, and 18.5 ± 2.5 mm Hg after 6 months, showing a stable reduction in IOP starting at 3 months. The treatment was successful in 74% of cases. The use of AGD decreased from 2.0 ± 1.0 at baseline to 1.1 ± 1.2 at 1 month, then increased to 1.7 ± 1.0 at 3 months and 2.2 ± 1.2 by 6 months. No severe complications or hypotony were reported. Conclusion: The combination of VEGF inhibitor injections and µCPC offers an effective, safe, and prompt treatment for NVG over a six-month period.
metadata.dc.relation.ispartof: The 19th Edition of the South-East European Ophthalmological Society Congress. October 18-19th, 2024, Chisinau, Republic of Moldova
URI: http://repository.usmf.md/handle/20.500.12710/30372
ISBN: 978-9975-82-393-7
Appears in Collections:The 19th Edition of the South-East European Ophthalmological Society Congress Abstract book. October 18-19th, 2024, Chisinau, Republic of Moldova



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback